Fernández, Óscar <br/><br/>
Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.  [electronic resource] 

 -  Clinical therapeutics  Aug 2017 
 - 1671-1679 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2017.06.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Delayed-Action Preparations--adverse effects<br/>Dimethyl Fumarate--adverse effects<br/>Female<br/>Glatiramer Acetate--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Interferon-beta--therapeutic use<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Recurrence<br/>Risk Assessment<br/>Treatment Outcome<br/>Young Adult